Tag Archives: pet ct

Hybrid Imaging
4
Feb

Overview

Hybrid imaging integrates functional and anatomic modalities in a single study. Examples include PET CT and PET MRI. These combinations improve localization and characterization of disease.

Clinical Benefits

Hybrid imaging increases diagnostic confidence and staging accuracy. It reduces the need for multiple separate studies. It supports precise therapy planning and monitoring.

Technical Considerations

Hybrid systems require coordinated acquisition and reconstruction protocols. Attenuation correction and registration are important for image quality. Workflow and scheduling considerations affect throughput.

Research Directions

Hybrid imaging enables novel tracer development and multiparametric analysis. It supports translational research and clinical trials. Ongoing work aims to improve quantitative accuracy and accessibility.

Imaging for Gynecologic Oncology
4
Feb

Overview

Imaging evaluates extent nodal involvement and metastatic disease in gynecologic malignancies. Modalities include ultrasound CT MRI and PET CT. Imaging guides surgical planning and adjuvant therapy decisions.

Pelvic MRI

MRI provides superior soft tissue contrast for local staging of cervical and endometrial cancers. It assesses tumor size parametrial invasion and nodal status. Standardized reporting improves multidisciplinary communication.

PET CT Role

PET CT detects nodal and distant metastatic disease in selected gynecologic cancers. It aids in recurrence detection and treatment planning. Tracer selection and timing influence sensitivity.

Surveillance and Recurrence

Imaging protocols for surveillance depend on tumor type stage and treatment. Early detection of recurrence may influence salvage therapy options. Multidisciplinary review ensures appropriate imaging intervals and modalities.

Imaging for Hematology
4
Feb

Overview

Imaging assesses marrow involvement splenic size and complications of hematologic disease. Modalities include MRI CT ultrasound and nuclear medicine. Imaging guides diagnosis staging and response assessment.

Marrow Imaging

MRI detects marrow infiltration edema and focal lesions in hematologic malignancies. Whole body MRI and PET CT assess disease burden and treatment response. Quantitative metrics support prognostication.

Splenic and Vascular Assessment

Ultrasound and CT evaluate splenomegaly portal hypertension and vascular complications. Imaging guides interventions and monitoring of therapy related effects. Correlation with laboratory data informs management.

Post Treatment Surveillance

Imaging monitors for relapse complications and treatment toxicity in hematologic patients. Choice of modality depends on disease type and clinical question. Multidisciplinary care integrates imaging into long term follow up.

Positron Emission Tomography PET
4
Feb

Overview

PET images physiologic and metabolic processes using radiotracers such as FDG and detects areas of altered metabolism with high sensitivity.

Technique

Radiotracer selection uptake time and attenuation correction are critical. PET is often combined with CT or MRI for anatomic localization.

Clinical Uses

Oncology staging and response assessment infection and inflammation imaging and neurologic metabolic studies.

Limitations and Safety

Radiation exposure from radiotracers and CT component. False positives from inflammatory uptake require clinical correlation.

Memorial Sloan Kettering Cancer Center Imaging
4
Feb

Overview

MSK imaging focuses on cancer diagnosis staging and treatment response assessment with integrated multidisciplinary care.

Specialties

Expertise in PET CT MRI and interventional oncology procedures tailored to cancer care.

Research and Education

Leads trials in imaging biomarkers radiotracer development and image guided therapies with strong translational focus.

Notable Programs

Close integration with surgical oncology medical oncology and radiation oncology for personalized cancer management.

Royal Marsden Hospital Imaging
4
Feb

Overview

Royal Marsden imaging provides dedicated oncologic imaging services with emphasis on clinical trials and novel imaging agents.

Specialties

Strengths in PET CT MRI and early phase imaging studies for novel therapeutics.

Research and Education

Collaborates with research institutes to translate imaging biomarkers into clinical trials and practice.

Notable Programs

Known for early adoption of theranostics and multidisciplinary cancer care pathways.